This Rockville-based biotech startup nabbed a $2.5 million investment - Technical.ly DC

Business

Dec. 17, 2019 11:17 am

This Rockville-based biotech startup nabbed a $2.5 million investment

Hememics Biotechnologies Inc. plans to use the investment from AMVI Partners to begin clinical research for FDA submission for its flagship biotech product, a point-of-care panel to test for sexually transmitted diseases.
Startups in the DMV region are advancing biotech products.

Startups in the DMV region are advancing biotech products.

(Photo by Pixabay user luvqs, used under a Creative Commons license)

Rockville, Maryland-based Hememics Biotechnologies Inc. has secured a $2.5 million investment from AMVI Partners, an international investment firm with offices in McLean, Virginia.

The startup is working on developing a handheld device equipped with a multiplex panel chip that is able to rapidly test a blood sample to detect bacteria or proteins in less than a minute. The initial device in development, named HEMEMICS, is a point-of-care panel to test for sexually transmitted diseases.

The company — one of the first of six health technology startups that the Northern Virginia-based Inova Health System invested in via its Inova Personalized Health Accelerator in 2017 — plans to use the investment to begin clinical research for a U.S. Food and Drug Administration submission for its flagship biotech product, it announced in a press release. Hememics connected with AMVI Partners through the Vietnamese American Business Council (VABC), a nonprofit based in McLean, Virginia, which has a mission to foster business opportunities between Vietnam and the U.S.

“Our long-term relationship with VABC has made this progress possible. This significant investment will enable us to achieve key milestones on our path to commercial availability,” said Hememics CSO and cofounder David Ho in a press release.

“We are thrilled to engage in this productive partnership with Vietnamese investors through AMVI Partners,” said Hememics CEO and cofounder John Warden in a statement. “Given the worldwide growth rates for STI such as chlamydia, gonorrhea and HPV, we are especially honored to have interest from the international investment community in our technology.”

The startup’s proprietary platform is protected by three patents, and the device doesn’t require refrigeration, according to its website. Here’s a visualization of how its technology works:

Advertisement

-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

Here’s what Procurated’s founder considered when making his first hire last year

Bethesda-based edtech startup Knowledge to Practice raised $3.7M in new funding

Revolution’s next Rise of the Rest road trip is heading to 4 states in April

SPONSORED

DC

How this software engineer’s career change has helped her make change in the world

Washington, D.C.

The Washington Post

Professional Services Engineering Lead

Apply Now

Washington, D.C.

The Washington Post

Digital Analyst – Audience Development & Analytics

Apply Now

Washington, D.C.

The Washington Post

Manager, Software Engineering, Professional Services

Apply Now

Revolution made nearly 100 investments in 2019

Blockchain tech Securrency just raised a $17.65M Series A

VEDA Data Solutions closed a $5M Series A

SPONSORED

DC

Introducing ‘Off the Sidelines,’ a new podcast series about startup investing

Philadelphia, PA - Center City

Odessa

Sr. Project Manager – ERP Implementations

Apply Now

Philadelphia, PA

Vistar Media

QA Engineer

Apply Now

Philadelphia, PA - Center City

Odessa

Business Architect

Apply Now

Sign-up for daily news updates from Technical.ly Dc

Do NOT follow this link or you will be banned from the site!